文献速递骨质疏松与代谢性骨病

绝经后女性循环二肽基肽酶4水平与骨质疏松性骨折的相关性

Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
PubMed 文献 · Osteoporos Int · 2016-11-19

这项在韩国多中心开展的病例对照研究纳入178例骨质疏松性骨折(OF)患者和178名年龄及体质指数匹配的对照,发现调整混杂因素后OF组血浆二肽基肽酶4(DPP4)水平显著更高(P=0.021),最高DPP4四分位组OF风险为最低四分位组的3.80倍(95%CI=1.53-9.42)。DPP4与所有骨转换标志物(BTM)正相关,与各部位骨密度(BMD)无显著关联,BTM可解释DPP4与OF关系的约一半。

要点

  • OF组血浆DPP4水平显著高于对照组(P=0.021)。
  • DPP4与所有BTM正相关,与各测量部位BMD无显著关联。
  • 最高DPP4四分位组OF风险为最低四分位组的3.80倍(95%CI=1.53-9.42)。

核心结论

  • DPP4可能至少部分通过介导骨转换率而与骨质疏松性骨折相关。
  • 循环DPP4水平可能是一种潜在生物标志物,可提高现有骨折风险评估模型的预测能力。

研究设计与样本

  • 在韩国多个中心开展的病例对照研究,纳入178例骨质疏松性骨折患者和178名年龄及体质指数匹配的对照。
  • 骨折通过访谈员辅助问卷和胸腰椎侧位X线片评估,所有受试者检测骨转换标志物、骨密度和血浆DPP4水平。

主要发现

  • 调整潜在混杂因素后,骨质疏松性骨折组DPP4水平显著高于无骨折组(P=0.021)。
  • 较高DPP4水平与所有骨转换标志物较高水平显著正相关,但与所有测量部位的骨密度无显著关联。
  • 对每种骨转换标志物额外调整后,DPP4水平在骨折组与无骨折组间的差异消失;对任何骨密度值调整后该差异未消失。
  • 骨转换标志物解释了DPP4与骨质疏松性骨折关系的约一半。
  • 调整包括股骨颈骨密度在内的潜在混杂因素后,最高DPP4四分位组骨质疏松性骨折风险为最低四分位组的3.80倍(95%CI=1.53-9.42)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Postmenopausal women with osteoporotic fracture (OF) had higher plasma dipeptidyl-peptidase 4 (DPP4) levels than those without. Furthermore, higher plasma DPP4 levels were significantly associated with higher bone turnover and a higher prevalence of OF. These results indicated that DPP4 may be associated with OF by mediating bone turnover rate. INTRODUCTION: Evidence indicates that dipeptidyl-peptidase 4 (DPP4) plays a distinct role in bone metabolism. However, there has been no report on the association, if any, between circulating DPP4 levels and osteoporosis-related phenotypes, including osteoporotic fracture (OF). Therefore, we performed a case-control study to investigate these associations in postmenopausal women. METHODS: This study was conducted in multiple centers in Korea. We enrolled 178 cases with OF and 178 age- and body mass index-matched controls. OF was assessed by an interviewer-assisted questionnaire and lateral thoracolumbar radiographs. Bone turnover markers (BTMs), bone mineral density (BMD), and plasma DPP4 levels were obtained in all subjects. RESULTS: After adjustment for potential confounders, subjects with OF had significantly higher DPP4 levels than those without (P = 0.021). Higher DPP4 levels were significantly positively associated with higher levels of all BTMs, but not with BMD at all measured sites. The differences in DPP4 levels according to OF status disappeared after an additional adjustment for each BTM, but not after adjustment for any BMD values. BTMs explained approximately half of the relationship between DPP4 and OF. The risk of OF was 3.80-fold (95% confidence interval = 1.53-9.42) higher in subjects in the highest DPP4 quartile than in those in the lowest quartile after adjustment for potential confounders, including femoral neck BMD. CONCLUSIONS: DPP4 may be associated with OF by at least partly mediating the bone turnover rate. Circulating DPP4 levels may be a potential biomarker that could increase the predictive power of current fracture risk assessment models.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Kim H, Baek KH, Lee SY, et al. Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women. Osteoporos Int. 2016. PMID: 27866216. doi:10.1007/s00198-016-3839-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。